About us
Contact
Location
News
World News
Clinical News
UK News
Get news headlines by email
JobSearch
Search
Manage job postings
Recruiters' Directory
Get jobs by email
Advertising rates
Contacts
Magazine
Latest issue
Search past issues
Search Corporate profiles
Free subscription
Have your say
Advertising
Contact
Awards and Events
European Marketeer
Marketeer
RBM
Representative
Clinical Researcher
Communications Team
Recruiter
Great Oxford Debate
Joint Working Projects
US Clinical Researcher
Clubs
SOPHIE
PharmaTimes Directors' Club
Find agency
Advertising
Recruitment
Advertise
Why advertise?
Website and Archive search
Go
JobSearch
Go
Email
Password
Login
Subscribe to the archive
Forgotten password
MAGAZINE AUDIT BY
Where am I? >
Home
>
Industry News
>
World News
LATEST WORLD NEWS
Abbott Labs to buy Facet Biotech in $722 million deal
Having rejected much lower hostile bids from partner Biogen Idec last year, Facet Biotech Corp has agreed to be acquired by Abbott Laboratories for $27 per share
Ark/Oxford BioMedica merger touted as Cerepro file is pulled
Ark Therapeutics is in talks about a possible sale after European regulators informed the UK firm that an expensive additional clinical trial is needed before its brain cancer drug Cerepro could be given the green light
Pfizer/Biotie schizophrenia pact coming to an end
Pfizer is ending a partnership with Biotie to develop schizophrenia treatments, the Finnish drugmaker has revealed
FDA panel backs InterMune's Esbriet for IPF
Shares in InterMune will soar today after advisors to the US Food and Drug Administration voted in favour of recommending Esbriet for approval as a treatment for lung scarring
FDA rejects Actelion's Zavesca for rare NP-C disease
Actelion’s bid to get a new use approved for Gaucher disease drug Zavesca has suffered a setback after regulators in the USA asked more information on the drug as a treatment for a rarer condition
Sanofi and Merck link up to form animal health giant
As big pharma looks to sustain growth as big-selling drugs go off-patent, Sanofi-Aventis and Merck & Co have said they are combining their animal health units in a move that will create a global leader in that field
More Headlines
GSK eyes more deals in India
Germany “to break pharma price monopoly"
Exelixis cuts workforce by 40% and XenoPort halves staff
Genmab shares sink as cancer drug fails in Phase III study
After Dimebon failure, where next for Alzheimer’s?
Pfizer brings out big guns to woo Ratiopharm
Roche stops RA drug development after deaths
AstraZeneca's cediranib fails in head-to-head with Avastin
Generics set to pummel Belgian pharma market growth
Australia court says Vioxx was “unfit” for use
Court backs five-year exclusivity for Shire's ADHD drug Vyvanse
FDA pledges more industry criminal prosecutions
Older >
Join PharmaTimes Directors Club
Find out more
PharmaTimes Club for Directors Secretaries
Learn more
LATEST JOBS
Clinical Nurse Advisor - Surgical & Critical Care
BUSINESS DEVELOPMENT MANAGER - HOMECARE
Secondary Care Representative
Theatre Sales Representative- Theatre Consumables
Marketing Manager
Business Manager - Oncology
PRODUCT MANAGER - HOMECARE
Sales Specialist - Surgical
Part-time Medical Representative
Territory Manger- North-West
Home
|
World News
|
Clinical News
|
UK News
|
Magazines
|
Competitions
|
Clubs
|
Jobs
|
Forums
|
Directory
RSS Feed
|
Advertising & Rates
|
About us
|
Contact
|
Subscribe
|
Privacy
|
Statistics
|
Maintained by DCSL